Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Oct 26 - Oct 31
Active cancer, especially hormone-sensitive types, where metabolic accelerators could be contraindicated
Studies show that inhibiting nicotinamide Nmethyltransferase (NNMT) enhances metabolic health by reducing adipose tissue accumulation, improving insulin sensitivity, and promoting better energy utilization
NuRev Peptides maintains a research-only policy and emphasizes transparency, documentation, and third-party laboratory verification where applicable
AOD9604 was originally developed after research on mice, but subsequent studies in human have shown no efficacy for the potential treatment of obesity
Dosage: 1-2 mcg/kg, 1-2 times daily via subcutaneous injection
